ARCHIVES

Lung Screening Advocates Say Verdict’s In, Attack NCI Randomized Trial As “Outdated.”

This article is from The Cancer Letter archive.

Vol. 32 No. 39 | November 3, 2006

Download PDF Visit The Full Archive

Related Articles

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

Proposed Surveillance Model Aims To Reduce Post-Treatment Pain

April 27, 2012

NCI Begins Latin American Cancer Research Network

April 10, 2009

Obituary: Sir Richard Doll, 92, epidemiologist who linked smoking to lung cancer.

July 29, 2005

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

NCI Committed To 50 Percent Mortality Reduction By 2000; DCPC Board Hears How That Will Be Done

January 20, 1984